Opinion

Video

Lp(a) Genetic Patterns

Jaime Murillo, MD, explores genetic inheritance patterns of Lp(a) from childhood to adulthood, highlighting stability, factors affecting measurement, and awareness challenges among those in the health care community.

This is a video synopsis/summary of an Insights involving Michael D. Shapiro, DO, and Jaime Murillo, MD.

Murillo delves into the genetic inheritance patterns of lipoprotein(a) (Lp[a]), stressing its stable nature from childhood to adulthood, unlike fluctuating factors like sugar levels. Emphasizing its genetic determination, he highlights that stable conditions ensure consistent Lp(a) levels, reducing the need for frequent measurements. However, he notes the lack of awareness among health care providers and payers due to the asymptomatic nature of Lp(a) until an adverse event occurs.

Murillo identifies key factors contributing to this unawareness, including reactive health care practices and the absence of a known treatment for Lp(a). He proposes educational campaigns for both health care providers and individuals to understand the risks associated with Lp(a), stressing lifestyle changes’ potential in reducing cardiovascular risks by 75%. Furthermore, he advocates for constant guideline updates and awareness initiatives to standardize Lp(a) measurement as part of routine care, fostering partnerships between providers and patients to manage associated risks effectively.

Video synopsis is AI-generated and reviewed by AJMC® editorial staff.

Related Videos
Video 6 -"Identifying the Most Impactful Disease Areas and Patient Populations for PDTs"
Video 5 - "Dawn of the Age of Adopting PDTs"
Video 5 - "Potential Consequences of Early Diagnosis of Alzheimer Disease"
Video 5 - "Potential Consequences of Early Diagnosis of Alzheimer Disease"
A panel of 4 experts on PDTs
A panel of 4 experts on PDTs
A panel of 5 experts on Alzheimer disease
A panel of 5 experts on Alzheimer disease
Video 2 - "SunRISe-1: Examining Combination Therapy for HR NMIBC"
Video 1 - "Comparing Long-Term Efficacy of Bladder-Preserving Therapies for NMIBC "
Related Content
CH LogoCenter for Biosimilars Logo